Performing phase I clinical trials of anticancer agents: perspectives from within the European union and Japan.
Forster, Martin D; Saijo, Nagahiro; Seymour, Lesley; Calvert, Hilary.
Clin Cancer Res
; 16(6): 1737-44, 2010 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-20215555
On the Necessity of Ethical Guidelines for Novel Neurotechnologies.
FDA should stand firm on stem-cell treatments.
Comprehensive analysis of clinical development and regulatory submission promotion schemes for oncologic drugs as the Japanese national projects.
Änderungen des Arzneimittelgesetzes durch die EU-Verordnung zu klinischen Prüfungen.
A New Challenge to Research Ethics: Patients-Led Research (PLR) and the Role of Internet Based Social Networks.
How Much Longer Will We Put Up With $100,000 Cancer Drugs?
Human Subject Protection; Acceptance of Data From Clinical Investigations for Medical Devices. Final rule.
Realizing the potential of synthetic biology.
Human studies: Reforms overdue for ethical reviewing.
Academic clinical research in the new regulatory environment.